Developer docs
API playgroundTry for free, no card

Search company profiles

LivingPhoenix

Full company profile

uuid0093ge4

Namestring
LivingPhoenix
Legal namestring
如凤凰再生科技发展(成都)有限公司
Company typeenum
Private
Founded yearint
2023
Descriptiontext

LivingPhoenix Regenerative Technologies Development (Chengdu) Co., Ltd. (如凤凰再生科技发展(成都)有限公司) is a Chengdu-based biotechnology company founded in 2023 that develops and commercializes third-generation triple-helix biomimetic extracellular matrix (ECM) collagen materials. The proprietary platform synthesizes collagen with a stable 120° triple-helix structure composed of glycine-proline-hydroxyproline (Gly-X-Y) repeating sequences that survives 121°C sterilization, addressing the limitations of animal-derived collagen (viral risk, immunogenicity) and recombinant collagen (lack of stable triple-helix structure). The company serves medical aesthetic clinics, dermatology hospitals, regenerative medicine researchers, and premium skincare consumers through a vertically integrated portfolio spanning raw materials, medical devices, and consumer skincare brands.

The technology platform supports four product lines: POGMENT (波格因) triple-helix biomimetic collagen raw material sold to downstream manufacturers; WEIYIMEI (稳年轻) Class II medical device skincare products validated by Beijing Hospital and Peking University Third Hospital with NMPA pre-approval; and consumer skincare brands SMARTENDER (智嫩) and Onlyfun (欧俪芳) sold via the company's Youzan e-commerce flagship store. Class II device trial production has been completed and Class III devices are under development, with applications spanning skin, cartilage, and broader tissue regeneration. POGMENT is protected by 6 Chinese invention patents and 6 PCT international patents, recognized under both Chinese national standards and US ASTM standards as biomimetic collagen, and has been published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology.

LivingPhoenix operates a product-led growth model with revenue generated through B2B raw material sales, B2B medical device sales to clinics and hospitals, B2C e-commerce sales of consumer skincare brands, and technology licensing and co-development partnerships. The company operates from Chengdu Tianfu International Bio-city, maintains a 28-PhD Sichuan Provincial Doctoral Innovation Station, and has applied for a total of 12 invention patents. Distribution channels include direct sales to medical institutions, the Youzan flagship store for consumer products, and international expo presence for global market development. Pricing is not publicly disclosed. No institutional funding rounds have been disclosed in available sources, indicating the company is currently founder-financed or bootstrapped.

Short descriptiontext

LivingPhoenix is a Chengdu-based biotechnology company founded in 2023 that develops third-generation triple-helix biomimetic ECM collagen raw materials, Class II medical devices, and consumer skincare products, serving medical aesthetic clinics, hospitals, and premium skincare consumers.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersShuangliu, China
HQ citystring
Shuangliu
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomimetic collagen materials, regenerative medicine technology, medical device manufacturing, skincare product development, ECM tissue engineering
Industry2 codes
1Dermocosmetics & Medical-Grade Skincare
CodeCRABAAAFPrimaryYes
2Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate)
CodeIMAMALACPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Biological Product (except Diagnostic) Manufacturing325414
  • Resin and Synthetic Rubber Manufacturing32521
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Plastic Materials, Synth Resins & Nonvulcan Elastomers2821
Product category
Biomimetic Collagen Materials and Regenerative Medicine
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1POGMENT Raw Material Sales
TypeOne Time License
Description

Sale of POGMENT (波格因) triple-helix biomimetic collagen raw material to downstream manufacturers in cosmetics, medical devices, and regenerative medicine industries.

mylivingphoenix.com
2Medical Device Products
TypeOne Time License
Description

Sale of Class II (二类) and Class III (三类) medical devices powered by POGMENT biomimetic collagen technology. WEIYIMEI (稳年轻) is the medical device skincare brand. Trial production completed for Class II devices; Class III devices in development.

mylivingphoenix.com
3Consumer Skincare Products
TypeOne Time License
Description

Sale of premium consumer skincare brands including SMARTENDER (智嫩) and Onlyfun (欧俪芳) through direct-to-consumer e-commerce and flagship store channels.

mylivingphoenix.com
4Technology Licensing & Co-development
TypeLicensing Royalties
Description

Licensing of proprietary biomimetic collagen technology and co-development partnerships with other brands and manufacturers.

mylivingphoenix.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1POGMENT (波格因)
Description

World's first triple-helix biomimetic collagen raw material ingredient that solves the thermal stability challenge

mylivingphoenix.com
+3 more records
Core offering1 text field

LivingPhoenix develops, manufactures, and sells a third-generation biomimetic triple-helix collagen platform marketed under POGMENT raw material, WEIYIMEI Class II medical devices, and consumer skincare brands SMARTENDER and Onlyfun. Its offering spans industrial biomaterial ingredients, clinically validated regenerative medical devices, and premium anti-aging skincare products powered by a synthetic collagen technology that mimics the natural triple-helix structure.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 4 Chinese invention patents granted for WEIYIMEI product line
+4 more records
Product overview1 text field

LivingPhoenix operates as a biotechnology company with a platform-plus-products architecture. The core technology is the Triple-Helix Biomimetic ECM Collagen Innovation Platform, which represents the third generation of biomimetic synthesis after animal extraction and gene recombination. This platform underpins multiple product lines: POGMENT (波格因) serves as the foundational raw material for triple-helix biomimetic collagen; WEIYIMEI (稳年轻) is the Class II medical device skincare line; SMARTENDER (智嫩) and Onlyfun (欧俪芳) are consumer-facing high-end skincare brands. The company is also developing Class III medical devices, with the technology suitable for skin, cartilage, and other tissue regeneration applications.

Product and service3 records
1POGMENT (波格因) Triple-Helix Biomimetic Collagen Raw Material
CategoryBiomimetic Collagen Raw Material
Description

POGMENT is the world's first triple-helix biomimetic collagen raw material that solves the thermal stability challenge. It uses synthetic technology to avoid viral and immunogenicity issues of animal-derived collagen while addressing recombinant collagen's lack of stable triple-helix structure, with superior bioactivity, durability, and decomposition resistance. The raw material is sold to downstream manufacturers in cosmetics, medical devices, and regenerative medicine industries.

2WEIYIMEI (微依美) Class II Medical Device Skincare Series
CategoryMedical Device (Class II)
Description

WEIYIMEI is China's first biomimetic collagen Class II medical device skincare product matrix utilizing POGMENT triple-helix biomimetic collagen technology for rapid repair and anti-aging effects, suitable for skin tissue regeneration applications and sold to medical aesthetic clinics and dermatology hospitals.

3SMARTENDER (智嫩) Premium Anti-Aging Skincare Series
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LivingPhoenix

Biomimetic Collagen Materials and Regenerative Medicinemylivingphoenix.com

LivingPhoenix is a Chengdu-based biotechnology company founded in 2023 that develops third-generation triple-helix biomimetic ECM collagen raw materials, Class II medical devices, and consumer skincare products, serving medical aesthetic clinics, hospitals, and premium skincare consumers.

What LivingPhoenix does

LivingPhoenix Regenerative Technologies Development (Chengdu) Co., Ltd. (如凤凰再生科技发展(成都)有限公司) is a Chengdu-based biotechnology company founded in 2023 that develops and commercializes third-generation triple-helix biomimetic extracellular matrix (ECM) collagen materials. The proprietary platform synthesizes collagen with a stable 120° triple-helix structure composed of glycine-proline-hydroxyproline (Gly-X-Y) repeating sequences that survives 121°C sterilization, addressing the limitations of animal-derived collagen (viral risk, immunogenicity) and recombinant collagen (lack of stable triple-helix structure). The company serves medical aesthetic clinics, dermatology hospitals, regenerative medicine researchers, and premium skincare consumers through a vertically integrated portfolio spanning raw materials, medical devices, and consumer skincare brands.

The technology platform supports four product lines: POGMENT (波格因) triple-helix biomimetic collagen raw material sold to downstream manufacturers; WEIYIMEI (稳年轻) Class II medical device skincare products validated by Beijing Hospital and Peking University Third Hospital with NMPA pre-approval; and consumer skincare brands SMARTENDER (智嫩) and Onlyfun (欧俪芳) sold via the company's Youzan e-commerce flagship store. Class II device trial production has been completed and Class III devices are under development, with applications spanning skin, cartilage, and broader tissue regeneration. POGMENT is protected by 6 Chinese invention patents and 6 PCT international patents, recognized under both Chinese national standards and US ASTM standards as biomimetic collagen, and has been published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology.

LivingPhoenix operates a product-led growth model with revenue generated through B2B raw material sales, B2B medical device sales to clinics and hospitals, B2C e-commerce sales of consumer skincare brands, and technology licensing and co-development partnerships. The company operates from Chengdu Tianfu International Bio-city, maintains a 28-PhD Sichuan Provincial Doctoral Innovation Station, and has applied for a total of 12 invention patents. Distribution channels include direct sales to medical institutions, the Youzan flagship store for consumer products, and international expo presence for global market development. Pricing is not publicly disclosed. No institutional funding rounds have been disclosed in available sources, indicating the company is currently founder-financed or bootstrapped.

LivingPhoenix firmographics

Firmographics
Name
LivingPhoenix
Legal name
如凤凰再生科技发展(成都)有限公司
Website
https://mylivingphoenix.com
Company type
Private
Founded year
2023
Operating status
Operating
Short description
LivingPhoenix is a Chengdu-based biotechnology company founded in 2023 that develops third-generation triple-helix biomimetic ECM collagen raw materials, Class II medical devices, and consumer skincare products, serving medical aesthetic clinics, hospitals, and premium skincare consumers.
Ownership category
akta.pro rank

LivingPhoenix industry classification

Industry
Product category
Biomimetic Collagen Materials and Regenerative Medicine
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414), Resin and Synthetic Rubber Manufacturing (32521)
SIC
Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844), Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821)
akta.pro primary industry
Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
akta.pro secondary industry
Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate) (IMAMALAC)

Keywords

  • Biomimetic collagen materials
  • Regenerative medicine technology
  • Medical device manufacturing
  • Skincare product development
  • ECM tissue engineering

Where LivingPhoenix is headquartered

Location

Headquarters

HQ city
Shuangliu
HQ country
China
HQ region
Asia

Offices3 records

Markets served

LivingPhoenix business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. POGMENT Raw Material Sales: Sale of POGMENT (波格因) triple-helix biomimetic collagen raw material to downstream manufacturers in cosmetics, medical devices, and regenerative medicine industries.
  2. Medical Device Products: Sale of Class II (二类) and Class III (三类) medical devices powered by POGMENT biomimetic collagen technology. WEIYIMEI (稳年轻) is the medical device skincare brand. Trial production completed for Class II devices; Class III devices in development.
  3. Consumer Skincare Products: Sale of premium consumer skincare brands including SMARTENDER (智嫩) and Onlyfun (欧俪芳) through direct-to-consumer e-commerce and flagship store channels.
  4. Technology Licensing & Co-development: Licensing of proprietary biomimetic collagen technology and co-development partnerships with other brands and manufacturers.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

LivingPhoenix product offering

Product offering

Core offering

LivingPhoenix develops, manufactures, and sells a third-generation biomimetic triple-helix collagen platform marketed under POGMENT raw material, WEIYIMEI Class II medical devices, and consumer skincare brands SMARTENDER and Onlyfun. Its offering spans industrial biomaterial ingredients, clinically validated regenerative medical devices, and premium anti-aging skincare products powered by a synthetic collagen technology that mimics the natural triple-helix structure.

Product overview

LivingPhoenix operates as a biotechnology company with a platform-plus-products architecture. The core technology is the Triple-Helix Biomimetic ECM Collagen Innovation Platform, which represents the third generation of biomimetic synthesis after animal extraction and gene recombination. This platform underpins multiple product lines: POGMENT (波格因) serves as the foundational raw material for triple-helix biomimetic collagen; WEIYIMEI (稳年轻) is the Class II medical device skincare line; SMARTENDER (智嫩) and Onlyfun (欧俪芳) are consumer-facing high-end skincare brands. The company is also developing Class III medical devices, with the technology suitable for skin, cartilage, and other tissue regeneration applications.

Differentiator

Problem solved

Functional benefit

Brands

  • POGMENT (波格因): World's first triple-helix biomimetic collagen raw material ingredient that solves the thermal stability challenge
  • WEIYIMEI (微依美)
  • Onlyfun (欧俪芳)
  • SMARTENDER (智嫩)

Products and services

  • POGMENT (波格因) Triple-Helix Biomimetic Collagen Raw Material POGMENT is the world's first triple-helix biomimetic collagen raw material that solves the thermal stability challenge. It uses synthetic technology to avoid viral and immunogenicity issues of animal-derived collagen while addressing recombinant collagen's lack of stable triple-helix structure, with superior bioactivity, durability, and decomposition resistance. The raw material is sold to downstream manufacturers in cosmetics, medical devices, and regenerative medicine industries.
  • WEIYIMEI (微依美) Class II Medical Device Skincare Series WEIYIMEI is China's first biomimetic collagen Class II medical device skincare product matrix utilizing POGMENT triple-helix biomimetic collagen technology for rapid repair and anti-aging effects, suitable for skin tissue regeneration applications and sold to medical aesthetic clinics and dermatology hospitals.
  • SMARTENDER (智嫩) Premium Anti-Aging Skincare Series

Quantifiable outcome

  • 4 Chinese invention patents granted for WEIYIMEI product line
  • +4 more outcomes

Companies that use LivingPhoenix

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

LivingPhoenix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

LivingPhoenix partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

LivingPhoenix competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

LivingPhoenix compliance and trust

Trust signal

Compliance4 records

LivingPhoenix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LivingPhoenix leadership team

Management profile

Number of profiles

Profiles4 records

LivingPhoenix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LivingPhoenix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LivingPhoenix

What does LivingPhoenix do?

LivingPhoenix develops, manufactures, and sells a third-generation biomimetic triple-helix collagen platform marketed under POGMENT raw material, WEIYIMEI Class II medical devices, and consumer skincare brands SMARTENDER and Onlyfun. Its offering spans industrial biomaterial ingredients, clinically validated regenerative medical devices, and premium anti-aging skincare products powered by a synthetic collagen technology that mimics the natural triple-helix structure.

Is LivingPhoenix a public or private company?

LivingPhoenix is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LivingPhoenix founded?

LivingPhoenix was founded in 2023.

Where is LivingPhoenix based?

LivingPhoenix is headquartered in Shuangliu, China, in the Asia region.

How does LivingPhoenix make money?

Four revenue lines are on record. POGMENT Raw Material Sales are the primary driver. The others are medical Device Products, consumer Skincare Products and technology Licensing & Co-development.

Does LivingPhoenix have an API?

No public API is recorded for LivingPhoenix.

What industry is LivingPhoenix in?

LivingPhoenix's product category is Biomimetic Collagen Materials and Regenerative Medicine. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of IMAMALAC, Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal Attention: POGMENT Biomimetic Collagen "Stable Triple-Helix Breakthrough" --Unconventional and AstonishingLivingPhoenix Regenerative Technologies presented its world-first triple-helix biomimetic collagen at twelve academic conferences across China, receiving significant acclaim from leading experts in the fields of aesthetic medicine and regenerative medicine. The global launch of their product, the Smartender® Bouncy Bar, occurred at the China International Import Expo, attracting substantial interest and feedback from nearly 1,000 attendees. These developments highlight LivingPhoenix's innovative role in advancing regenerative medicine and their commitment to integrating scientific research with industry applications.PR NewswireKyoto University Engineering Ph.D. Team Achieves Technology Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge"LivingPhoenix Regenerative Technologies Development (Chengdu) Co., Ltd. presented its globally pioneering POGMENT triple-helix biomimetic collagen technology at the 2025 Chinese Biomaterials Congress in Shaoxing, Zhejiang, where independent patent assessment confirmed the technology as "globally pioneering and internationally leading." The product, originating from fundamental research initiated in 2001 by Kyoto University's Professor Masao Tanihara and developed through collaboration with Japanese and Chinese institutions, has completed NMPA registration and passed classification review as a Class III medical device. The injectable biomimetic collagen lyophilized fiber is the first product in a planned pipeline targeting functional cosmetics, medical dressings, fillers/implants, and tissue engineering applications.PR NewswireGLOBAL FIRST "High-Definition Image": Decoding the "Code of Youth" - LivingPhoenix's POGMENT Collagen Breakthrough Fills Global GapLivingPhoenix Technology announced that its POGMENT triple-helix biomimetic collagen has achieved the world's first high-resolution, molecular-level visualization of collagen fiber bundles using Cryo-Electron Microscopy (Cryo-EM), filling an international gap in structural understanding of collagen fiber self-assembly mechanisms. The fully synthetic collagen has overcome thermal instability challenges, reached factory-level mass production with unit costs comparable to recombinant collagen and expected to drop to 50%, and has been incorporated into China's medical industry standard (YY/T1955-2025). China's biomimetic collagen market is projected to surge from less than 1 million yuan in 2025 to 6.778 billion yuan in 2030, with POGMENT positioned as a high-performance alternative for medical aesthetics and regenerative medicine.